Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ChiCTR-TTRCC-14005168Phase 4Completed
Phase 4, randomised, open-label trial of febuxostat (3 arms), sponsored by First Affiliated Hospital, Zhejiang University School of Medicine. Primary endpoints: Cmax, AUC0-t and 11 more. Started May 2013; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on ChiCTR-TTRCC-14005168.